The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Inhibition of Cyclin-dependent Kinase 5 Activity Protects Pancreatic Beta Cells from Glucotoxicity
Open accessAbstract
Type 2 diabetes (T2D) and Alzheimer disease are degenerative diseases that may share common pathophysiologic mechanisms. Neuronal dysfunction in Alzheimer patients has been linked to overactivity of the cyclin-dependent kinase 5 (CDK5) and its activator p35. Both of these proteins are expressed in the insulin-producing beta cells of the pancreas. Further, glucose enhances p35 gene expression, promoting the formation of active p35/CDK5 complexes that regulate the expression of the insulin gene. In T2D, chronic elevations of glucose, glucotoxicity, impair beta cell function. We therefore postulated that CDK5 and p35 may be responsible for this beta cell impairment and that inhibition of CDK5 might have a beneficial effect. To test this hypothesis, the pancreatic cell line INS-1 was selected as a known in vitro model of glucotoxicity, and roscovitine (10 mum) was used as a CDK5 inhibitor. Chronic exposure of INS-1 cells to high glucose (20-30 mm) reduced both insulin mRNA levels and the activity of an insulin promoter reporter gene. Inhibition of CDK5 prevented this decrease of insulin gene expression. We used DNA binding (gel shift) assays and Western immunoblots to demonstrate that cellular levels of the transcription factor PDX-1, normally decreased by glucotoxicity, were preserved with CDK5 inhibition, as was the binding of PDX-1 to the insulin promoter. Analyses of nuclear and cytoplasmic PDX-1 protein levels revealed that CDK5 inhibition restores nuclear PDX-1, without affecting its cytoplasmic concentration, suggesting that CDK5 regulates the nuclear/cytoplasm partitioning of PDX-1. Using a Myc-tagged PDX-1 construct, we showed that the translocation of PDX-1 from the nucleus to the cytoplasm during glucotoxic conditions was prevented when CDK5 was inhibited. These studies indicate that CDK5 plays a role in the loss of beta cell function under glucotoxic conditions and that CDK5 inhibitors could have therapeutic value for T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the French genome-wide scan (10), variants in both the HHEX and SLC30A8 genes were implicated in T2D susceptibility.”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A fourth genome-wide association scan, in French subjects, recently reported independent evidence for a T2D signal in this region (10).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Across the four T2D scans completed (5, 6, 7, 10), TCF7L2 clearly emerges as the largest association signal.”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One of the remaining four loci (HHEX/IDE) represents a strong replication of findings recently reported (10).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [10]
Experimental — accuracy not yet measuredIn the citing paper
“CDK5 has been implicated in the regulation of pancreatic beta cell function, through formation of p35/CDK5 complexes that downregulate insulin expression (11, 12).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [11]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress-Induced Binding of the Transcription Factor CHOP to a Novel DNA Control Element
Ubeda, M., Wang, X.-Z., Zinszner, H., Wu, I., F. Habener, J., & Ron, D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1479 · Cited by 310
Self-citationLeahy, J. L., Cooper, H. E., Deal, D. A., & Weir, G. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112389 · Cited by 292
Evolution of β-Cell Dysfunction in the Male Zucker Diabetic Fatty Rat
Tokuyama, Y., Sturis, J., DePaoli, A. M., Takeda, J., Stoffel, M., Tang, J., Sun, X., Polonsky, K. S., & Bell, G. I. (1995) · Diabetes · doi:10.2337/diab.44.12.1447 · Cited by 281
Cdk5 deregulation in the pathogenesis of Alzheimer's disease
Cruz, J. C., & Tsai, L.-H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.001 · Cited by 258
Role of Oxidative Stress in Pancreatic β-Cell Dysfunction
Kajimoto, Y., & Kaneto, H. (2004) · Mitochondrial Pathogenesis · doi:10.1007/978-3-662-41088-2_17 · Cited by 248
Harmon, J. S., Stein, R., & Robertson, R. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410345200 · Cited by 233
Glucotoxicity and β-Cell Failure in Type 2 Diabetes Mellitus
Kaiser, Ν., Leibowitz, G., & Nesher, R. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.1.5 · Cited by 210
Kawamori, D., Kajimoto, Y., Kaneto, H., Umayahara, Y., Fujitani, Y., Miyatsuka, T., Watada, H., Leibiger, I. B., Yamasaki, Y., & Hori, M. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2896 · Cited by 209
Role of Oxidative Stress in Pancreatic β‐Cell Dysfunction
KAJIMOTO, Y., & KANETO, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1293.017 · Cited by 206
Sharma, A. (1995) · Molecular Endocrinology · doi:10.1210/me.9.9.1127 · Cited by 164
Research works printed but not linked: 2
- Srinivasan, 2002, Am. J. Physiol., 283, E784
- Sharma, 1995, Mol. Endocrinol., 9, 1127
Cited by
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2043 · Cited by 1,072
Genome–wide association studies provide new insights into type 2 diabetes aetiology
Frayling, T. M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2178 · Cited by 594
Volkmar, M., Dedeurwaerder, S., Cunha, D. A., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo‐Esteve, M., Naamane, N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.503 · Cited by 420
“Hyperglycaemia-caused overactivation of CDK5 may contribute to β -cell glucotoxicity (Ubeda et al , 2006).”
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Pellarin, I., Dall’Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 304
The Emerging Genetic Architecture of Type 2 Diabetes
Doria, A., Patti, M.-E., & Kahn, C. R. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.006 · Cited by 305
The replication of β cells in normal physiology, in disease and for therapy
Butler, P. C., Meier, J. J., Butler, A. E., & Bhushan, A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0647 · Cited by 268
“although it is not yet known if this is through actions on cell numbers or secretion within cells (because TF7L2 acts through the wingless-type MMTV integration site [WNT] family signaling pathway, an effect on cell cycle would not be unexpected); and, finally, CDKAL1 (CDK5 regulatory subunit-associated protein 1-like…”
BackgroundCho, Y. M., Kim, T. H., Lim, S., Choi, S. H., Shin, H. D., Lee, H. K., Park, K. S., & Jang, H. C. (2009) · Diabetologia · doi:10.1007/s00125-008-1196-4 · Cited by 243
Impaired insulin secretion increases the risk of Alzheimer disease
Rönnemaa, E., Zethelius, B., Sundelöf, J., Sundström, J., Degerman-Gunnarsson, M., Berne, C., Lannfelt, L., & Kilander, L. (2008) · Neurology · doi:10.1212/01.wnl.0000310646.32212.3a · Cited by 241
Kaniuk, N. A., Kiraly, M., Bates, H., Vranic, M., Volchuk, A., & Brumell, J. H. (2007) · Diabetes · doi:10.2337/db06-1160 · Cited by 223
Lee, Y.-H., Kang, E. S., Kim, S. H., Han, S. J., Kim, C. H., Kim, H. J., Ahn, C. W., Cha, B. S., Nam, M., Nam, C. M., et al. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0341-8 · Cited by 177
Ravetti, M. G., Rosso, O. A., Berretta, R. E., & Moscato, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010153 · Cited by 153
Mao, H., Li, Q., & Gao, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045882 · Cited by 132
Vascular risk factors and Alzheimer’s disease
Cechetto, D. F., Hachinski, V., & Whitehead, S. N. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.743 · Cited by 149
Kono, T., Ahn, G., Moss, D. R., Gann, L., Zarain‐Herzberg, Á., Nishiki, Y., Fueger, P. T., Ogihara, T., & Evans‐Molina, C. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1181 · Cited by 124
Zhang, L., Lai, E., Teodoro, T., & Volchuk, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805477200 · Cited by 114
Wnt Signaling in Pancreatic Islets
Liu, Z., & Habener, J. F. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_17 · Cited by 95
Self-citationWang, Y., Nie, M., Li, W., Ping, F., Hu, Y., Ma, L., Gao, J., & Liu, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026953 · Cited by 96
Stančáková, A., Pihlajamäki, J., Kuusisto, J., Stefan, N., Fritsche, A., Häring, H. U., Andreozzi, F., Succurro, E., Sesti, G., Boesgaard, T. W., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2218 · Cited by 88
CDKAL1 and type 2 diabetes: a global meta-analysis
Dehwah, M. A. S., Wang, M., & Huang, Q. (2010) · Genetics and Molecular Research · doi:10.4238/vol9-2gmr802 · Cited by 85
Eggers, J. P., Grandgenett, P. M., Collisson, E. C., Lewallen, M. E., Tremayne, J. R., Singh, P. K., Swanson, B. J., Andersen, J. M., Caffrey, T. C., High, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2288 · Cited by 81
Wei, F., & Tomizawa, K. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0099 · Cited by 76
Deletion of CDKAL1 Affects Mitochondrial ATP Generation and First-Phase Insulin Exocytosis
Ohara‐Imaizumi, M., Yoshida, M., Aoyagi, K., Saito, T., Okamura, T., Takenaka, H., Akimoto, Y., Nakamichi, Y., Yanobu‐Takanashi, R., Nishiwaki, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015553 · Cited by 74
Hou, Z., Li, H., Gao, L., Pan, L., Zhao, J., & Li, G. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.03.004 · Cited by 78
Han, D. S. C., Yang, B., Olson, L. K., Greenstein, A., Baek, S., Claycombe, K., Goudreau, J. L., Yu, S.-W., & Kim, E. K. (2009) · Biochemical Journal · doi:10.1042/bj20090429 · Cited by 62
Karunakaran, U., Elumalai, S., Moon, J. S., Jeon, J., Kim, N. D., Park, K., Won, K. C., Leem, J., & Lee, I. K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0052 · Cited by 63
Mechanisms of Disease: genetic insights into the etiology of type 2 diabetes and obesity
Lindgren, C. M., & McCarthy, M. I. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0723 · Cited by 63
Cyclin-Dependent Kinase 5 Promotes Pancreatic β-Cell Survival via Fak-Akt Signaling Pathways
Daval, M., Gurlo, T., Costes, S., Huang, C., & Butler, P. C. (2011) · Diabetes · doi:10.2337/db10-1048 · Cited by 52
Increased Cdk5/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats
Zhu, W., Shi, H., Wang, S., Xu, C., Jiang, W., Wang, X., Wu, P., Li, Q., Ding, Z., & Lü, L. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000915 · Cited by 56
A kinase of many talents: non-neuronal functions of CDK5 in development and disease
Sharma, S., & Siciński, P. (2020) · Open Biology · doi:10.1098/rsob.190287 · Cited by 59
Pharmacogenetics of novel glucose-lowering drugs
Rathmann, W., & Bongaerts, B. W. C. (2021) · Diabetologia · doi:10.1007/s00125-021-05402-w · Cited by 55
Jin, X., Fang, R., Fan, P., Lipeng, Z., Zhang, B., Lu, X., & Liu, T. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1466-7 · Cited by 54
Ghassibe‐Sabbagh, M., Haber, M., Salloum, A. K., Al-Sarraj, Y. A., Akle, Y., Hirbli, K., Romanos, J., Mouzaya, F., Gauguier, D., Platt, D. E., et al. (2014) · Scientific Reports · doi:10.1038/srep07351 · Cited by 52
Chistiakov, D. A., Potapov, V. A., Андреевна, С. С., Бельчикова, Л. Н., Суплотова, Л. А., & Nosikov, V. V. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0299-4 · Cited by 45
A new era for Type 2 diabetes genetics
Zeggini, E. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02274.x · Cited by 46
Cdk5 in Oncology: Recent Advances and Future Prospects
Lenjisa, J. L., Tadesse, S., Khair, N. Z., Kumarasiri, M., Yu, M., Albrecht, H., Milne, R. W., & Wang, S. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0097 · Cited by 47
Liebl, J., Fürst, R., Vollmar, A. M., & Zahler, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.020 · Cited by 46
GCK, GCKR, FADS1, DGKB/TMEM195 and CDKAL1 Gene Polymorphisms in Women with Gestational Diabetes
Tarnowski, M., Malinowski, D., Pawlak, K. M., Dziedziejko, V., Safranow, K., & Pawlik, A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.11.009 · Cited by 44
Wang, S., Zhou, Y., Zhang, Y., He, X., Zhao, X., Zhao, H., & Liu, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108895 · Cited by 39
Guo, F., Long, W., Zhou, W., Zhang, B., Liu, J., & Yu, B. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4857-7 · Cited by 39
MOPAT: a graph-based method to predict recurrent cis -regulatory modules from known motifs
Hu, J., Hu, H., & Li, X. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn407 · Cited by 35
Karunakaran, U., Lee, J. E., Elumalai, S., Moon, J. S., & Won, K. C. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.038 · Cited by 33
Habitual coffee intake, genetic polymorphisms, and type 2 diabetes
Lee, J. K., Kim, K., Ahn, Y., Yang, M., & Lee, J. E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0805 · Cited by 35
Xiao, S., Zeng, X., Fan, Y., Su, Y., Ma, Q., Zhu, J., & Yao, H. (2016) · PubMed Central · doi:10.12659/msm.895347 · Cited by 33
Nikitin, A. G., Potapov, V. Y., Brovkina, O., Koksharova, E., Ходырев, Д. С., Philippov, Y. I., Michurova, M. S., Шамхалова, М. Ш., Vikulova, O. K., Андреевна, С. С., et al. (2017) · PeerJ · doi:10.7717/peerj.3414 · Cited by 31
Lin, P., Chen, L., Li, D., Liu, J., Yang, N., Sun, Y., Xu, Y., Fu, Y., & Hou, X. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.217.59 · Cited by 33
Genetics of type 2 diabetes mellitus and obesity—a review
Jafar‐Mohammadi, B., & McCarthy, M. I. (2008) · Annals of Medicine · doi:10.1080/07853890701670421 · Cited by 35
Osada, U. N., Sunagawa, H., Terauchi, Y., & Ueda, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154821 · Cited by 31
Lu, F., Qian, Y., Li, H., Dong, M., Lin, Y., Du, J., Lin, Y., Chen, J., Shen, C., Jin, G., et al. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.25 · Cited by 29
Luo, G.-C., Kong, X., Lü, L., Xu, X., Wang, H., & Ma, X. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.11.016 · Cited by 33
Ryoo, H., Woo, J., Kim, Y., & Lee, C. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.6 · Cited by 30
Ghosh, C., Das, N., Saha, S., Kundu, T., Sircar, D., & Roy, P. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00953-6 · Cited by 29
Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications
Oner, M., Lin, E., Chen, M., Hsu, F.-N., Prince, G. M. S. H., Chiu, K.-Y., Teng, C. J., Yang, T., Wang, H., Yue, C.-H., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163881 · Cited by 29
Genome-wide association scans for Type 2 diabetes: new insights into biology and therapy
McCarthy, M. I., & Zeggini, E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.008 · Cited by 31
Kang, J., Guan, R., Zhao, Y., & Chen, Y. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-00999-y · Cited by 32
Bao, X. Y., Peng, B., & Yang, M. S. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0995-8 · Cited by 26
Genetic Risk Factors and Gene–Lifestyle Interactions in Gestational Diabetes
Jääskeläinen, T. J., & Klemetti, M. M. (2022) · Nutrients · doi:10.3390/nu14224799 · Cited by 34
Mahdizade, A. H., Bahreiny, S. S., Bastani, M., Dabbagh, M. R., Aghaei, M., Malayeri, F. A., YousefiFard, A., & Taghizadeh, E. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01272-7 · Cited by 25
Novel genomic signals of recent selection in an Ethiopian population
Ayele, F. T., Adeyemo, A., Chen, G., Hailu, E., Aseffa, A., Davey, G., Newport, M. J., & Rotimi, C. N. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.233 · Cited by 26
Christodoulou, M., Avgeris, M., Kokkinopoulou, I., Maratou, E., Mitrou, P., Kontos, C. K., Pappas, E., Boutati, E. I., Scorilas, A., & Fragoulis, E. G. (2019) · Scientific Reports · doi:10.1038/s41598-018-37856-1 · Cited by 30
Zheng, Y.-L., Li, C., Hu, Y., Cao, L., Wang, H., Li, B., Lu, X., Bao, L., Luo, H., Shukla, V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063332 · Cited by 27
Li, Y., Wang, L., Lu, X.-Z., Yang, Z., Wang, X., Zhou, C., Xu, J., Qian, Y., & Chen, A. (2013) · Scientific Reports · doi:10.1038/srep03131 · Cited by 24
A Cdk5 Inhibitor Enhances the Induction of Insulin Secretion by Exendin-4 Both in Vitro and in Vivo
Kitani, K., Oguma, S., Nishiki, T., Ohmori, I., Galons, H., Matsui, H., Meijer, L., & Tomizawa, K. (2007) · The Journal of Physiological Sciences · doi:10.2170/physiolsci.rp006607 · Cited by 25
Amtul, Z., Hill, D. J., Arany, E. J., & Cechetto, D. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-22985-4 · Cited by 23
tRNA modifications and islet function
Wei, F., & Tomizawa, K. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13405 · Cited by 24
Li, C., Shen, K., Yang, M., Yang, Y., Tao, W., He, S., Shi, L., Yao, Y., & Li, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s288587 · Cited by 24
Haney, S. A., Zhao, J., Tiwari, S., Eng, K., Guey, L. T., & Tien, E. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064946 · Cited by 25
Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus
Ahmed, D., & Sharma, M. (2011) · International Journal of Endocrinology · doi:10.1155/2011/530274 · Cited by 23
Miyaki, K., Oo, T. N., Song, Y., Lwin, H., 冨田, 裕., Hoshino, H., Suzuki, N., & Muramatsu, M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq281 · Cited by 21
Cdk5r1 Overexpression Induces Primary β -Cell Proliferation
Draney, C., Hobson, A., Grover, S. G., Jack, B. O., & Tessem, J. S. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6375804 · Cited by 21
Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis
Zheng, Y.-L., Hu, Y., Zhang, A., Wang, W., Li, B., Amin, N. D., Grant, P. G., & Pant, H. C. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.067 · Cited by 20
Franks, P. W., & Nettleton, J. A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq280 · Cited by 21
Tian, Y., Xu, J., Huang, T. M., Cui, J., Zhang, W., Song, W., Chen, H., Huang, P., Yang, S., Wang, L., et al. (2019) · Kidney & Blood Pressure Research · doi:10.1159/000503175 · Cited by 19
Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Liu, X., Zhang, N., Zhang, S., & Xu, P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15502 · Cited by 17
Martin, D. J., Allagnat, F., Gesina, E., Caille, D., Gjinovci, A., Waeber, G., Meda, P., & Haefliger, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045844 · Cited by 17
The association analysis polymorphism of CDKAL1 and diabetic retinopathy in Chinese Han population
Liu, N., Xiong, Q., Wu, H., Li, Y.-L., YANG, Z. K., Tao, X., Du, Y., Lü, B., Hu, R., Wang, X., et al. (2016) · International Journal of Ophthalmology · doi:10.18240/ijo.2016.05.12 · Cited by 15
Yu, X., Song, L., Wei, S., Wen, X., & Liu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.722674 · Cited by 14
Association of the CDKAL1 polymorphism rs10946398 with type 2 diabetes mellitus in adults
Liu, X., Liang, J., Geng, H., Xu, W. G., Teng, F., & Yang, M. (2020) · Medicine · doi:10.1097/md.0000000000021383 · Cited by 13
Frequent Loss of Genome Gap Region in 4p16.3 Subtelomere in Early-Onset Type 2 Diabetes Mellitus
Kudo, H., Emi, M., Ishigaki, Y., Tsunoda, U., Hinokio, Y., Ishii, M., Sato, H., Yamada, T., Katagiri, H., & Oka, Y. (2011) · Experimental Diabetes Research · doi:10.1155/2011/498460 · Cited by 14
Genetics of Gestational Diabetes Mellitus
Kwak, S. H., Jang, H. C., & Park, K. S. (2009) · Journal of Korean Medical Association · doi:10.5124/jkma.2009.52.7.688 · Cited by 13
Tuerxunyiming, M., Mohemaiti, P., Wufuer, H., & Tuheti, A. (2015) · PubMed Central · Cited by 12
Genome-wide association study on complex diseases: genetic statis-tical issues
Yan, W. (2008) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2008.00543 · Cited by 12
Vera, D. M., López-Gambero, A. J., Navarro, J. A., Sanjuan, C., Baixerás, E., Decara, J. M., & de Fonseca, F. R. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.379015 · Cited by 11
Translational implications of the β-cell epigenome in diabetes mellitus
Johnson, J. S., & Evans‐Molina, C. (2014) · Translational research · doi:10.1016/j.trsl.2014.03.002 · Cited by 10
Soltani, G., Hatefi, Z., Salehi, A. R., Khosravi, S., Ghiasi, M. R., Teke, K., Aminorroaya, A., & Salehi, R. (2018) · Advanced Biomedical Research · doi:10.4103/abr.abr_144_17 · Cited by 10
Mechanistic insights and approaches for beta cell regeneration
Karampelias, C., Liu, K., Tengholm, A., & Andersson, O. (2025) · Nature Chemical Biology · doi:10.1038/s41589-024-01822-y · Cited by 9
Zeng, Q., Zou, D., Gu, S., Han, F., Cao, S., Wei, Y., & Guo, R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.783078 · Cited by 9
Liu, X., Li, L., Chen, Z., Lu, Z., Shi, Y., & Zhao, Y. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903215490 · Cited by 9
Rabhi, N., Desevin, K., Cortez, B. N., Hekman, R. M., Lin, J. Z., Emili, A., & Farmer, S. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-99871-z · Cited by 8
Caron, D., Winstall, É., Inaguma, Y., Michaud, S., Lettre, F., Bourassa, S., Kelly, I., Poirier, G. G., Faure, R. L., & Tanguay, R. M. (2008) · Journal of Proteome Research · doi:10.1021/pr8002497 · Cited by 8
Nakane, T., Ido, A., Higuchi, T., Todaka, H., Morisawa, K., Nagamine, T., Fukunaga, K., Sakamoto, S., Murao, K., & Sugiyama, Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.036 · Cited by 7
Nakane, T., Matsumoto, S., Iida, S., Ido, A., Fukunaga, K., Murao, K., & Sugiyama, Y. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111240 · Cited by 7
Involvement of the Ca2+-responsive transactivator in high glucose-induced β-cell apoptosis
Men, X., Peng, L., Wang, H., Zhang, W., Xu, S., Fang, Q., Liu, H., Yang, W., & Lou, J. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0286 · Cited by 6
Kornprobst, J. (2014) · Wiley eBooks · doi:10.1002/9783527335855.marprod026 · Cited by 6
Gyan, W. R., Zhang, H., Shao, T., Yang, T., Wei, Y., Li, M., Che, X., Zeng, Q., & Guo, R. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01874-8 · Cited by 6
Liang, J., Zhu, Y., Liu, X.-K., Qiu, Q. Q., Sun, Y., Wang, Y., Pei, Y., Yang, M., & Qi, L. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-109607 · Cited by 5
Metadata
- Authors
- Ubeda, M., Rukstalis, J. M., & Habener, J. F.
- Affiliations
- Harvard University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Habener, Joel F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 281
- Issue
- 39
- Pages
- 28858-28864
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002427009
- Cited by
- 138
- References
- 25
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 9 · 2020: 3 · 2019: 8 · 2018: 6 · 2017: 10 · 2016: 5 · 2015: 3 · 2014: 8 · 2013: 4 · 2012: 8
- FWCI
- 12.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5152 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, DK 55365, R01DK055365, DK057521-06)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cyclin-dependent kinase 5, p35, glucotoxicity, pancreatic beta cells, type 2 diabetes, insulin gene expression, PDX1, nuclear-cytoplasmic translocation, roscovitine, INS-1 cells, insulin promoter, Alzheimer's disease, CDK5 inhibitors
- MeSH terms
- Animals, Cell Nucleus, Cytoplasm, Diabetes Mellitus, Type 2, Enzyme Inhibitors, Glucose, Insulin, Time Factors, Trans-Activators, Homeodomain Proteins, RNA, Small Interfering, Cell Line, Tumor, Insulin-Secreting Cells, Cyclin-Dependent Kinase 5, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.